Compare Remala Abadi Tbk. (DATA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Remala Abadi Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Remala Abadi Tbk. trades at Rp1,920 (market cap 2.64T), while UBC Medical Indonesia Tbk. trades at Rp161 (market cap 635.95B). The key difference: Remala Abadi Tbk. is far larger — about 4.2× UBC Medical Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| DATA | LABS | |
|---|---|---|
Market Cap | 2.64T | 635.95B |
Indicative Equilibrium Price | 1,920 | 163 |
Indicative Equilibrium Volume | 68 | 16 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Remala Abadi Tbk.
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Read more on DATA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
